Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using cascade CNN-LSTM-FCNs to identify AI-altered video based on eye state sequence.

PloS one·2022
Same author

EDR-Net: Lightweight Deep Neural Network Architecture for Detecting Referable Diabetic Retinopathy.

IEEE transactions on biomedical circuits and systems·2022
Same author

Non-parametric multiple inputs prediction model for magnetic field dependent complex modulus of magnetorheological elastomer.

Scientific reports·2022
Same author

Advancement in biosensor: "Telediagnosis" and "remote digital imaging".

Biotechnology and applied biochemistry·2021
Same author

Biosensing human blood clotting factor by dual probes: Evaluation by deep long short-term memory networks in time series forecasting.

Biotechnology and applied biochemistry·2021
Same author

Enhancing Photocurrent Performance Based on Photoanode Thickness and Surface Plasmon Resonance Using Ag-TiO<sub>2</sub> Nanocomposites in Dye-Sensitized Solar Cells.

Materials (Basel, Switzerland)·2019

Related Experiment Video

Updated: Jun 19, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

Exceptional performance with minimal data using a generative adversarial network for alzheimer's disease

Pui Ching Wong1, Shahrum Shah Abdullah2, Mohd Ibrahim Shapiai3

  • 1Biologically Inspired System and Technology Laboratory, Department of Electronic Systems Engineering, Malaysia-Japan International Institute of Technology, Universiti Teknologi Malaysia, Kuala Lumpur, Malaysia. puiching1997@graduate.utm.my.

Scientific Reports
|July 23, 2024
PubMed
Summary

Generative adversarial networks (GANs) address data scarcity in Alzheimer's disease (AD) classification. This deep learning approach enables high accuracy with reduced medical imaging data, overcoming privacy and imbalance challenges.

More Related Videos

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer&#39;s Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

814
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K

Related Experiment Videos

Last Updated: Jun 19, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K
Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer&#39;s Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

814
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K

Area of Science:

  • Artificial Intelligence
  • Medical Imaging
  • Neuroscience

Background:

  • Deep learning for Alzheimer's disease (AD) classification is limited by scarce medical imaging data due to privacy regulations.
  • Open-access datasets like OASIS often present imbalanced class distributions, further complicating model training.

Purpose of the Study:

  • To propose and evaluate a generative adversarial network (GAN) integrated approach for enhancing Alzheimer's disease classification with limited data.
  • To address data scarcity and class imbalance issues in medical image datasets for AD research.

Main Methods:

  • Utilized a generative adversarial network (GAN) for data augmentation, generating synthetic MRI data.
  • Trained the GAN model using experimental data from the Open Access Series of Imaging Studies (OASIS) database.
  • Integrated synthetic data into a pretrained convolutional neural network (CNN) for multistage AD classification.

Main Results:

  • Achieved a multistage Alzheimer's disease classification accuracy exceeding 80% with a reduced dataset.
  • Demonstrated the effectiveness of GANs in overcoming data scarcity for medical image analysis.
  • Showcased comparable accuracy to models trained on larger, more balanced datasets.

Conclusions:

  • Generative adversarial networks (GANs) offer a viable solution to the challenge of insufficient data in Alzheimer's disease classification.
  • GAN-based data augmentation can significantly improve deep learning model performance in medical imaging research.
  • This approach holds promise for advancing AD diagnosis and research despite data access limitations.